Fennec Pharmaceuticals Inc.'s (NASDAQ:FENC) largest shareholders are individual investors who were rewarded as market cap surged US$25m last week

2d ago, source:

Every investor in Fennec Pharmaceuticals Inc. ( NASDAQ:FENC) should be aware of the most powerful shareholder groups. And the ...

Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update

2d ago, source:

Total Net Revenues of $25.4 Million, Including $18.0 Million in Licensing Revenue from Recently Announced Norgine ...

Fennec Pharmaceuticals: Temporary Setbacks with Strong Long-Term Outlook

1d ago, source:

Fennec Pharmaceuticals (FENC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...

The Fennec Pharmaceuticals Inc (FENC) Stock expansion path ahead

1d ago, source: bovnews

Cantor Fitzgerald raised the price target for the Fennec Pharmaceuticals Inc (NASDAQ:FENC) stock from “a Neutral” to “an Overweight”. The rating was released on November 22, 2022, according to finviz.

FENC Fennec Pharmaceuticals Inc.

2mon ago, source: Seeking Alpha

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company’s product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention ...

FRX:CA Fennec Pharmaceuticals Inc.

9d ago, source: Seeking Alpha

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company’s product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention ...

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call Transcript

1mon ago, source: Insider Monkey

Dipesh Patel: And then final question. Does Fennec plan to use any of the upfront cash from the Norgine transaction to expand its pipeline? If so, what kind of opportunities do you plan to pursue ...

After Two FDA Rejections, Fennec Pharma Lead Drug Scores US Approval For Chemo-Induced Hearing Loss

2mon ago, source: AOL

The FDA approved Fennec Pharmaceuticals Inc's (NASDAQ: FENC) Pedmark to reduce the risk of chemo-induced ototoxicity in pediatric patients. Pedmark is indicated for pediatric patients one month of ...

Fennec Pharmaceuticals Inc FENC

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Fennec Pharmaceuticals Inc. (FENC)

17d ago, source: Yahoo Finance

Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its full year and fourth quarter 2023 ...

Fennec Pharmaceuticals Inc FENC

27d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...